RecruitingNot ApplicableNCT06216002

Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery

Incidence of Residual Neuromuscular Blockade in Patients With Frailty Undergoing Gynecologic Cancer Surgery


Sponsor

Mahidol University

Enrollment

622 participants

Start Date

Jan 2, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes, heightened incidence of postoperative complications, increased mortality rates, and prolonged hospital length of stay. Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery. The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty.


Eligibility

Sex: FEMALEMin Age: 18 Years

Inclusion Criteria2

  • Age \>,= 18 years
  • Patients undergoing elective gynecologic-oncology surgery

Exclusion Criteria4

  • Unable to communicate Thai
  • Unable to understand the questionnaire
  • Preexisting neuromuscular disease
  • Preexisting disease involved wrist that may affect the nerve stimulator examination

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTTrain of four nerve stimulator

Patient receive nerve stimulation by TOF-scan equipment at recovery room after surgery.


Locations(1)

Anesthesiology department, Siriraj hospital, Mahidol University

Bangkok, Bangkok, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06216002


Related Trials